Throughout the campaign trail, President Trump made several promises to voters on various policy points. Some have come true – such as lowering taxes via the Republican Tax Plan. Others are still waiting in the wings. And that includes his promises to lower healthcare costs. That plan was recently announced and is the beginning stages of taking shape. A big piece of the plan is centered around lowering drug prices for Americans.
With the potential for lower profits for drug makers, many investors are beginning to question if their lucrative dividends and buybacks are at risk.
The truth is, the major drug makers will be just fine. Much of the plan seems to be all bark and no bite. Investors in the sector shouldn’t be too worried.
Dividend.com has a dedicated page that tracks all healthcare stocks. You can find out the company count within each industry and get the latest dividend yield.